P/E ratio for Natera (NTRA)
P/E ratio as of April 2024 (TTM): -18.1
According to Natera's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -18.1079. At the end of 2022 the company had a P/E ratio of -7.21.
P/E ratio history for Natera from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -7.21 | -60% |
| 2021 | -18.0 | -48.73% |
| 2020 | -35.2 | 88.93% |
| 2019 | -18.6 | 197.33% |
| 2018 | -6.26 | 77.57% |
| 2017 | -3.53 | -41.29% |
| 2016 | -6.01 | -16.01% |
| 2015 | -7.15 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | 30.1 | -266.00% | 🇺🇸 USA |
 Prothena PRTA | -7.45 | -58.84% | 🇮🇪 Ireland |
 Paratek Pharmaceuticals
PRTK | -2.03 | -88.80% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.